ID: f2cde881-ad97-4c0c-808f-d89931731f50
Hypothesis
Test hypothesis 1
🎯 Composite 50%💱 $0.50proposed
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 0 oppose
🧪 Overview
No data yet for this section.
🧬 Mechanism
No curated mechanism pathway recorded for this hypothesis.
⚖️ Evidence
⚖️ Evidence Matrix5 supports0 contradicts
Supports
Double-blind test of the effects of distant intention on water crystal formation.
Supports
Conducting and Writing Quantitative and Qualitative Research.
Supports
Hypothesis testing and sample size considerations for the test-negative design.
Supports
A hypothesis test of feasibility for external pilot trials assessing recruitment, follow-up, and adherence rates.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for this gene.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0
Price History
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF the hypothesized mechanism is operative in the disease state, THEN we will detect a dose-dependent response in disease-relevant outcomes across three escalating dose levels compared to baseline wit | Monotonic dose-response relationship with ≥30% improvement in disease score at highest dose vs. no improvement at lowest dose, with intermediate effect at middl | — no observation — | pending | 0.40 |
| IF the intervention modulates the target pathway as hypothesized, THEN we will observe a statistically significant change in the primary biomarker levels compared to control group within 4 weeks of tr | A ≥25% change from baseline in the specified biomarker in the intervention group relative to vehicle/placebo control | — no observation — | pending | 0.45 |
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF the intervention modulates the target pathway as hypothesized, THEN we will observe a statistically significant change in the primary biomarker levels compared to control group within 4 weeks of treatment initiation.
Predicted outcome: A ≥25% change from baseline in the specified biomarker in the intervention group relative to vehicle/placebo control
Falsification: No statistically significant difference in biomarker levels between intervention and control groups (p > 0.05) after 4 weeks, or change <15% in the predicted direction
pendingconf 40%
IF the hypothesized mechanism is operative in the disease state, THEN we will detect a dose-dependent response in disease-relevant outcomes across three escalating dose levels compared to baseline within 8 weeks.
Predicted outcome: Monotonic dose-response relationship with ≥30% improvement in disease score at highest dose vs. no improvement at lowest dose, with intermediate effec
Falsification: Non-dose-dependent response pattern, equal or worse outcomes at highest dose compared to lowest dose, or >20% dropout rate obscuring dose-response assessment
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.